KR20250023329A - 투여 형태 내부의 코팅 및 이의 적용 - Google Patents

투여 형태 내부의 코팅 및 이의 적용 Download PDF

Info

Publication number
KR20250023329A
KR20250023329A KR1020247027473A KR20247027473A KR20250023329A KR 20250023329 A KR20250023329 A KR 20250023329A KR 1020247027473 A KR1020247027473 A KR 1020247027473A KR 20247027473 A KR20247027473 A KR 20247027473A KR 20250023329 A KR20250023329 A KR 20250023329A
Authority
KR
South Korea
Prior art keywords
mass
dosage form
coating formulation
choline
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247027473A
Other languages
English (en)
Korean (ko)
Inventor
클레이튼 에릭슨
렌 에이. 곤잘레스
Original Assignee
발켐 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 발켐 코포레이션 filed Critical 발켐 코포레이션
Publication of KR20250023329A publication Critical patent/KR20250023329A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020247027473A 2022-03-11 2023-03-10 투여 형태 내부의 코팅 및 이의 적용 Pending KR20250023329A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263318946P 2022-03-11 2022-03-11
US63/318,946 2022-03-11
PCT/US2023/064173 WO2023173111A2 (en) 2022-03-11 2023-03-10 Intra-dosage form coatings and applications thereof

Publications (1)

Publication Number Publication Date
KR20250023329A true KR20250023329A (ko) 2025-02-18

Family

ID=87936115

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247027473A Pending KR20250023329A (ko) 2022-03-11 2023-03-10 투여 형태 내부의 코팅 및 이의 적용

Country Status (6)

Country Link
US (1) US20250073175A1 (https=)
EP (1) EP4489731A4 (https=)
JP (1) JP2025506698A (https=)
KR (1) KR20250023329A (https=)
CN (1) CN118946346A (https=)
WO (1) WO2023173111A2 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007419D0 (en) * 2000-03-27 2000-05-17 Smithkline Beecham Gmbh Composition
US20070292508A1 (en) * 2006-06-05 2007-12-20 Balchem Corporation Orally disintegrating dosage forms
CA3013795A1 (en) * 2016-02-17 2017-08-24 Corr-Jensen Inc. Time release vitamins and minerals in edible oils
US20220193033A1 (en) * 2019-04-30 2022-06-23 Dsm Ip Assets B.V. New delivery system for specific water-soluble vitamins

Also Published As

Publication number Publication date
EP4489731A4 (en) 2026-03-11
EP4489731A2 (en) 2025-01-15
WO2023173111A3 (en) 2023-12-07
US20250073175A1 (en) 2025-03-06
CN118946346A (zh) 2024-11-12
WO2023173111A2 (en) 2023-09-14
JP2025506698A (ja) 2025-03-13

Similar Documents

Publication Publication Date Title
US9492451B2 (en) Stable compositions of tetrahydrobiopterin
KR20180124053A (ko) 비타민 b의 이중층 정제 및 그의 제조 방법
EP3027178A2 (en) Stabilized modified release folic acid derivative composition, its therapeutic use and methods of manufacture
US20240023589A1 (en) Tablettable formulation of lutein and/or zeaxanthin
JP2018104393A (ja) 固形製剤
AU2014349782A1 (en) Slow-release solid oral compositions
KR20250023329A (ko) 투여 형태 내부의 코팅 및 이의 적용
JP2000281574A (ja) 心臓血管保健のためのビタミン処方物
JP4674955B2 (ja) アミノ糖含有製剤
US9549937B2 (en) Composition containing phospholipid-DHA and folate
WO2012127431A1 (en) Stabilized compositions of tetrahydrobiopterin
JP2020111532A (ja) ビタミンｂ１類を配合する固形製剤
JP5158922B2 (ja) ビタミンｂ１２類含有組成物
US20250275926A1 (en) Multilayer formulation comprising modified tapioca starch for controlled-release of active agents
JP2001122788A (ja) 医薬用固形組成物
JP2004168761A (ja) アミノ糖類含有製剤
JP2005281324A (ja) アミノ糖含有製剤
KR20230136513A (ko) 비타민 c의 안정한 서방성 제형 및 이의 제조 방법
JP2019199486A (ja) アミノ糖含有製剤
JP2011068614A (ja) ビタミン製剤
JP2018127500A (ja) アミノ糖含有製剤
JP2017214432A (ja) アミノ糖含有製剤
JP2016222726A (ja) アミノ糖含有製剤
JP2010180254A (ja) アミノ糖含有製剤
JP2013032406A (ja) アミノ糖含有製剤

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20240816

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application